Winter is coming and so is FDA news! Take a moment to check out some recent FDA announcements.
Big news for people with multiple myeloma! A new immunotherapy was just approved for adults who had received two or more treatments before, including lenalidomideand a proteasome inhibitor.
How can phones change the way researchers look at data? The FDA is working on finding out.
The lymphoma community just got some good news– the FDA is fast-tracking a potential treatment.
Huntington’s disease has limited treatment options, but many are hoping that this is the first step towards better options.